Skip to content
Screener

Annexon ANNX Enterprise value

Enterprise value at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$65.61B+15.0%
Omeros logo
OmerosOMER
$1.22B+108%
Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
$372.63M+3,155%
Jade Biosciences logo
Jade BiosciencesJBIO
$638.62M
Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
$3.82B+565%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$1.04B+166%

Other financials

Income statement

See full
Operating income-$46.1M+19.8%
Net income-$44.1M+18.8%
EPS (diluted)-$0.23+37.8%

Balance sheet

See full
Cash & equivalents$175.2M+80.4%
Total debt$25.4M-10.2%
Total equity$204.5M-16.1%
Total assets$262.9M-13.2%

Cash flow

See full
Operating cash flow-$46.8M+6.5%
CapEx--100%
Free cash flow-$46.8M+6.6%

Valuation

See full
Market cap$886.39M+244%

Returns & leverage

See full
Return on equity-87.6%+42.3pp
Debt / equity0.1×0.0×
Current ratio6.4×-1.6×

Where this comes from

Calculated from Annexon’s reported figures.

The source filing: Annexon’s 10-Q, filed May 7, 2026. Open the filing →

Filed
May 7, 2026, 4:12 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-211931

FAQ

What is Annexon's enterprise value?
Annexon (ANNX) reported enterprise value of $676M in Q1 2026.
How has Annexon's enterprise value changed year-over-year?
Annexon's enterprise value increased by 373.0% year-over-year, from $142.93M to $676M.
What is the long-term trend for Annexon's enterprise value?
Over 4 years (2021 to 2025), Annexon's enterprise value has grown at a 11.2% compound annual growth rate (CAGR), from $400.67M to $612.41M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.

Ask your AI about Annexon's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude